APEX1 and cancer: Among those, we were interested in particular in liver (LIHC)52–56, lung (LUAD)57–60 and pancreatic (PAAD)61–65 cancer datasets, as the essential role of APE1 in the tumorigenic processes of these cancer types is already well established.